Medtronic will add a heart failure implant and pipeline products in its $1.1 billion acquisition of HeartWare. The deal will accelerate the development of HeartWare's products and round out Medtronic's Cardiac Rhythm & Heart Failure division.
Philips has acquired Northern Ireland's PathXL, which specializes in image analysis and tissue pathology. The financial details were not disclosed.
Bayer, which is making moves to acquire agrochemical giant Monsanto, is said to be mulling a sale of its radiology supplies business potentially worth more than $3 billion, Reuters reported.
EQT has enlisted the bankers at JPMorgan to handle the sale of BSN Medical, which could be worth more than €2 billion ($2.2 billion), Reuters reported. The Swedish buyout firm originally acquired BSN in 2012.
Terumo will acquire Sequent Medical, which is working on a minimally invasive device to treat intracranial aneurysms. The Japanese devicemaker will pay $280 million up front for the Aliso Viejo, CA-based startup, with an additional $100 million to follow if development or commercial milestones are achieved.
Johnson & Johnson has been sitting on its OneTouch Via patch-based insulin delivery system for a while now, and the tech is finally being launched. It is slated to debut the patch in limited ex-U.S. markets before year end, with a U.S. launch planned for "shortly thereafter," the company said.
Wall Street knew that Zimmer Biomet would have almost $5 billion in cash to spend over the next few years. And it expected the orthopedics company to plow much of that cash into M&A. Now, Zimmer has taken a step toward that with a purchase of spinal surgery player LDR Holding for about $1 billion.
Spine specialist NuVasive bolstered its product lineup when it acquired Ellipse in January. Now, the San Diego-based company is looking toward increasing its value-based healthcare offerings with the $98 million acquisition of Biotronic NeuroNetwork, which monitors patients' nervous systems during surgery.
Abbott and Alere aren't on the same page regarding the former's $5.8 billion acquisition of the latter. Abbott announced on Wednesday that it is auditing Alere's books, while the diagnostics maker--despite being under a federal investigation for its international sales practices--said it still expected the acquisition to close as planned.
Myriad Genetics has acquired Siemens spinout Sividon Diagnostics for €35 million ($39.1 million) up front with the potential for €15 million ($16.8 million) in performance-based milestones.